Evidence map›Paper›PMID 36386185›Full record

ReviewFrontiers in pharmacology2022

Potential of nanoformulations in malaria treatment.

Janaina Braga Chaves, Bianca Portugal Tavares de Moraes, Stela Regina Ferrarini, Francisco Noé da Fonseca, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Advancing liposome technology for innovative strategies against malaria.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Janaina Braga ChavesImmunopharmacology Laboratory, Department of Biochemistry, Federal University of the State of Rio de Janeiro-UNIRIO, Rio de Janeiro, Brazil.
Bianca Portugal Tavares de MoraesImmunopharmacology Laboratory, Department of Biochemistry, Federal University of the State of Rio de Janeiro-UNIRIO, Rio de Janeiro, Brazil.
Stela Regina FerrariniPharmaceutical Nanotechnology Laboratory, Federal University of Mato Grosso of Sinop Campus-UFMT, Cuiabá, Brazil.
Francisco Noé da FonsecaEmpresa Brasileira de Pesquisa Agropecuária, Parque Estação Biológica-PqEB, EMBRAPA, Brasília, Brazil.
Adriana Ribeiro SilvaImmunopharmacology Laboratory, Oswaldo Cruz Foundation, FIOCRUZ-UNIRIO, Rio de Janeiro, Brazil.
Cassiano Felippe Gonçalves-de-AlbuquerqueImmunopharmacology Laboratory, Department of Biochemistry, Federal University of the State of Rio de Janeiro-UNIRIO, Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is caused by the protozoan

Indexed as

infectious diseasemalariananotechnologypre-clinical studytreatment

Identifiers

PMID36386185
PMCPMC9645116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.